Company Information
- Type:
- Company
- Country:
- Portugal
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Privately Held
- Global Compact Status:
- Active
- Participant Since
- 19 February 2004
- Next Communication on Progress (COP) due on:
- 31 July 2025
Communication On Progress
| Published On | Title | Level/Status |
|---|---|---|
| 03-Jul-2024 | 2024 Communication on Progress | Submitted |
| 23-Nov-2023 | 2023 Communication on Progress | Submitted |
| 26-Jul-2022 | Social Responsability Report 2021 | Active |
| 25-Jul-2021 | Social Responsability Report 2020 | Active |
| 23-Jul-2020 | Communication on Progress | Active |
| 22-Jul-2019 | Social Responsibility Report 2018 | Active |
| 05-Jul-2018 | Communication on Progress | Active |
| 12-Oct-2016 | Communication on Progress | Active |
| 02-Apr-2015 | Communication on Progress | Learner |
| 02-Apr-2013 | Communication on Progress | Learner |
| 09-Dec-2011 | Communication on Progress | Learner |
| 08-Sep-2010 | 2010 Communication on Progress | Not applicable |
| 14-Sep-2009 | Social Responsibility Report 2008 | Not applicable |
| 12-Dec-2007 | Responsabilidade Social | Not applicable |
| 12-Dec-2006 | Social Responsibility | Not applicable |
Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.
Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP , for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.